Katz M E, Grosbach A B, Wein A, Glick J H
Cancer Clin Trials. 1978 Winter;1(4):247-71.
Even in advanced stages, testicular germ cell tumors are now curable. Pathologic classification proposed by W.H.O. affords more precise histologic definition; nevertheless, an improved staging classification more relevant to combination chemotherapy is required. Diagnostic evaluation should include the newer serum protein markers, lymphangiography as well as ultrasound and/or computerized axial tomography when clinically indicated. Combination chemotherapy drug regimens have made a major impact on survival of patients with testicular germ cell tumors because they can induce a high percentage of durable complete remissions. Only prospective trials can define the optimum number of drugs needed and the length of time of treatment to obtain cure. The role of combined modality therapy (radiation, reductive surgery, chemotherapy) needs to be further defined. It is hoped that ongoing clinical trials will answer many of these important questions.
即使处于晚期,睾丸生殖细胞肿瘤目前也可治愈。世界卫生组织提出的病理分类提供了更精确的组织学定义;然而,需要一种与联合化疗更相关的改进分期分类。诊断评估应包括更新的血清蛋白标志物、淋巴管造影以及在临床指征明确时进行超声和/或计算机断层扫描。联合化疗方案对睾丸生殖细胞肿瘤患者的生存产生了重大影响,因为它们可诱导高比例的持久完全缓解。只有前瞻性试验才能确定获得治愈所需的最佳药物数量和治疗时间长度。综合治疗(放疗、减瘤手术、化疗)的作用需要进一步明确。希望正在进行的临床试验能回答许多此类重要问题。